Hot Pursuit     18-Jun-24
Lupin Ltd slips for fifth straight session
Lupin Ltd is quoting at Rs 1577.3, down 1.67% on the day as on 13:19 IST on the NSE. The stock jumped 91.15% in last one year as compared to a 25.48% rally in NIFTY and a 48.98% spurt in the Nifty Pharma index.

Lupin Ltd is down for a fifth straight session today. The stock is quoting at Rs 1577.3, down 1.67% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.29% on the day, quoting at 23534.15. The Sensex is at 77203.56, up 0.27%.Lupin Ltd has lost around 6.33% in last one month.Meanwhile, Nifty Pharma index of which Lupin Ltd is a constituent, has increased around 2.9% in last one month and is currently quoting at 19895.65, down 0.67% on the day. The volume in the stock stood at 8.73 lakh shares today, compared to the daily average of 14.24 lakh shares in last one month.

The benchmark June futures contract for the stock is quoting at Rs 1582.3, down 1.43% on the day. Lupin Ltd jumped 91.15% in last one year as compared to a 25.48% rally in NIFTY and a 48.98% spurt in the Nifty Pharma index.

The PE of the stock is 31.42 based on TTM earnings ending March 24.

Previous News
  Lupin to develop next-gen inhalers using Honeywell's Solstice® Air propellant
 ( Corporate News - 20-May-25   19:07 )
  Lupin
 ( Results - Analysis 15-May-25   10:48 )
  Lupin receives USFDA approval for Rivaroxaban Tablets
 ( Corporate News - 15-May-25   16:21 )
  Board of Lupin recommends final dividend
 ( Corporate News - 15-May-25   10:06 )
  Stock Alert: Eicher Motors, Tata Power Company, Lupin, Le Travenues Tech, Tilakanagar Inds
 ( Market Commentary - Stock Alert 15-May-25   08:06 )
  Lupin consolidated net profit rises 114.93% in the March 2025 quarter
 ( Results - Announcements 15-May-25   07:42 )
  Lupin launches Tolvaptan Tablets in US market with 180-day exclusivity
 ( Corporate News - 13-May-25   15:03 )
  Lupin rises after launching Talvaptan tablets in US market
 ( Hot Pursuit - 13-May-25   12:25 )
  Lupin gets USFDA nod for Eslicarbazepine Acetate tablets
 ( Hot Pursuit - 08-May-25   08:26 )
  Aurobindo Pharma Ltd Slips 3.92%, BSE Healthcare index Shed 1.06%
 ( Hot Pursuit - 06-May-25   09:30 )
  Lupin announces board meeting date
 ( Corporate News - 30-Apr-25   11:10 )
Other Stories
  Interglobe Aviation Q4 PAT rises 62% YoY to Rs 3,067 cr; recommends dividend of Rs 10/sh
  22-May-25   16:14
  BSE drops as SEBI mulls Tuesday expiry for NSE contracts
  22-May-25   16:12
  Deepak Fertilisers records over 21% YoY growth in Q4 PAT to Rs 278 crore
  22-May-25   16:05
  ICRA revises its outlook on LT rating of Utkarsh Small Finance Bank to 'negative'
  22-May-25   15:50
  Mehai Tech Q4 PAT soars to Rs 1 crore
  22-May-25   15:40
  Crisil Ratings assigns 'A2' rating to ST facilities of Dreamfolks Services
  22-May-25   15:37
  Mankind Pharma slides after Q4 PAT drops 11% YoY to Rs 421 cr
  22-May-25   15:37
  Subros Q4 PAT climbs 52% YoY of Rs 46 cr
  22-May-25   15:30
  Crisil Ratings upgrades ratings of Sportking India to 'A+' with 'stable' outlook
  22-May-25   15:27
  Bajel Projects slides as PAT drops 32% YoY in Q4 FY25
  22-May-25   15:08
Back Top